How Much Weight Should I Lose Per Week on Zepbound?

Last reviewed: July 8, 2026

Last updated: July 8, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Zepbound (tirzepatide) reduces appetite and improves blood sugar control by activating dual GLP-1 and GIP receptors in the brain and gut. Most people lose 1 to 2 pounds weekly during the first 12 weeks, with cumulative weight loss reaching 15–22% of baseline body weight by week 72 in clinical trials. Your individual pace depends on starting weight, genetics, diet adherence, and how your body responds to dose increases.

Realistic Weekly Weight Loss Rates on Tirzepatide

Clinical data from Zepbound trials shows an average weight loss of 1–2 pounds per week during the dose-escalation phase (weeks 4–16), when doses increase from 2.5 mg to 15 mg. After reaching your maintenance dose, weekly loss often slows to 0.5–1.5 pounds as your body adapts to the medication. Weight loss is not linear—some weeks you may see 3 pounds drop, while other weeks show minimal change due to water retention, hormonal cycles, or metabolic adaptation.

Individual variation is significant and predictable. People with a higher starting body weight tend to lose more total pounds weekly than those closer to goal weight. Age, insulin resistance, physical activity level, and dietary protein intake all influence your personal trajectory. PlexusDx's Precision Peptide Genetic Test examines variants in GLP1R, GIPR, FTO, and MC4R genes to reveal your inherited metabolic strengths and potential response patterns before you start treatment.

Why Your Weekly Loss May Vary Over Time

Weight loss typically follows a three-phase pattern: rapid initial loss (weeks 1–8), a plateau phase (weeks 9–16), and then renewed loss as your body adjusts metabolically. The first phase often shows the most dramatic numbers because your body releases water and glycogen alongside fat loss. Once you reach a stable maintenance dose, your metabolism may temporarily resist further loss—this is completely normal and does not mean the medication stopped working.

Hormonal factors, meal timing, sodium intake, and stress all influence weekly fluctuations. Women may notice larger weekly swings around their menstrual cycle due to estrogen and progesterone effects on fluid retention. Strength training can also mask fat loss temporarily because muscle weighs more than fat. Tracking progress via body measurements, how clothes fit, or energy levels provides a more complete picture than the scale alone, especially during plateau weeks.

How Your Genetics Relate to GLP-1 Pathways

PlexusDx's Precision Peptide Genetic Test identifies genetic variants that influence how your body responds to tirzepatide and other GLP-1 agonists. The FTO rs9939609 variant, for example, is associated with increased appetite set-point and baseline body weight—people carrying this variant often experience stronger appetite suppression benefits from GLP-1 therapy. The GLP1R rs6923761 variant affects how your cells bind and respond to the GLP-1 signal, potentially influencing both efficacy and side-effect tolerability.

The PlexusDx Precision Peptide Genetic Test analyzes GIPR, and MC4R (rs17782313) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Optimizing Your Weight Loss With PlexusDx Tirzepatide

PlexusDx compounded tirzepatide injection starts at $289/mo (or $249/mo on the 6-month plan) across all dose levels—your dose may need to go up, but your price won't. Unlike retail Zepbound, which ties cost to pen strength, PlexusDx offers flat pricing so dose escalation never triggers a price jump. All medications ship from licensed 503A compounding pharmacies, require no insurance, and are HSA/FSA eligible. This pricing model removes financial barriers to finding your optimal dose for maximum weekly loss.

To maximize your weekly results, combine medication with consistent protein intake (25–35 grams per meal), stay hydrated, prioritize sleep, and move your body daily. Some patients see faster initial loss with slightly more aggressive calorie reduction in week 1–4, then shift to a sustainable deficit once nausea subsides. Your PlexusDx provider can help adjust your regimen if you're losing too quickly (which may signal muscle loss) or stalling (which may indicate a dose-timing or lifestyle factor). Regular check-ins ensure you're hitting a healthy, sustainable pace of 1–2 pounds weekly.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $289/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Is 1–2 pounds per week safe while taking tirzepatide?

Yes, 1–2 pounds weekly is considered safe and healthy for most adults on GLP-1 agonists. Clinical trials support this pace, and it reflects a calorie deficit of roughly 500–1,000 calories daily—a sustainable level that preserves muscle and metabolic function. Faster loss (3+ pounds weekly) may indicate excessive calorie restriction or water loss, which your PlexusDx provider can adjust.

What does clinical trial data show for total tirzepatide weight loss?

The ZEPBOUND trials (SUMO 1–4) demonstrated average weight loss of 15–22% of baseline body weight over 72 weeks (approximately 35–60 pounds for a 250-pound starting weight). Participants on the 15 mg maintenance dose saw the largest losses; those on lower doses showed 10–15% reductions. Individual results ranged from 5% to 35% based on genetics, adherence, and lifestyle factors.

Does PlexusDx pricing change if I need a higher tirzepatide dose?

No. PlexusDx compounded tirzepatide injection is $289 per month flat—your dose may need to go up, but your price won't. This removes cost barriers to reaching your optimal therapeutic dose over 16 weeks of dose escalation.

What side effects might slow my weekly weight loss progress?

Nausea, constipation, and vomiting can reduce your ability to eat protein-rich meals consistently, potentially slowing weight loss or causing muscle loss. These effects typically fade after 3–4 weeks at each dose level. Your provider may recommend dose-escalation adjustments, dietary changes, or anti-nausea strategies to keep you on track. Staying hydrated and eating smaller, frequent meals often improves tolerance and preserves steady weekly loss.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

No — the Precision Peptide Genetic Test does not predict your response to Zepbound or any specific medication. It analyzes pathway-level variants (GLP1R, GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Zepbound For Losing Weight
• Mounjaro Weight Loss By Week
• Wegovy Vs Zepbound Weight Loss
• Zepbound For Weight Loss

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.